LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。


As DSCSA enforcement moves the pharmaceutical industry toward fully serialized, interoperable data exchange, pharmacies must ensure they are using Global Location Numbers (GLNs) correctly and consistently. Whether a pharmacy is dispensing, receiving, or participating in EPCIS data exchange with trading partners, having properly assigned and well-managed GLNs is essential for accurate tracing and compliance.
This guide explains how pharmacies can obtain GLNs, how many they need, and the best practices for managing them across a store, chain, or network.
A pharmacy’s GLNs originate from its GS1 Company Prefix, a unique identifier licensed directly from GS1. This prefix forms the foundation for creating GLNs, GTINs, and other GS1 identifiers used across the supply chain.
To obtain a prefix:
Once the prefix is assigned, the organization can generate as many GLNs as needed within that prefix range.
GS1 requires that GLNs remain:
A GLN may represent a:
The key rule:
If something changes in a way that affects trading partner understanding—ownership, function, or physical location—you must assign a new GLN.
The number of GLNs needed depends on operational complexity.
A single independent pharmacy may need:
A regional or national chain may require:
The more locations and internal functions a business has, the more GLNs are needed to accurately represent its supply chain footprint.
GLNs are created from your GS1 Company Prefix, which requires an annual subscription. Costs depend on:
There is no separate fee per GLN—once you have a prefix, you can generate GLNs as required.
However, failing to renew your GS1 subscription can invalidate your identifiers, causing compliance issues and trading partner data mismatches.
Accurate GLN management is essential for DSCSA compliance and EPCIS interoperability. These best practices help ensure clean, reliable, and predictable GLN usage.
Pharmacies should maintain a consistent naming system to clearly distinguish different types of GLNs.
Examples:
Clear naming prevents internal confusion and supports smooth onboarding with manufacturers and wholesalers.
Every pharmacy organization should maintain a documented hierarchy showing how GLNs relate to each other:
A hierarchy ensures:
For multi-store chains, hierarchy management is essential for avoiding duplicated or inconsistent GLN assignments across different regions.
Common GLN problems include:
To avoid issues:
Incorrect or stale GLNs are a leading cause of EPCIS mismatches and DSCSA compliance delays.
A GLN should be retired when the location or function it identifies is permanently changed in a way that affects trading partner understanding.
Examples requiring a new GLN:
A GLN should not be reused for a new purpose once retired. Reuse creates ambiguity and can cause EPCIS failures.
Obtaining a GLN is straightforward, but managing GLNs correctly is essential for DSCSA compliance and accurate EPCIS data exchange. Pharmacies must understand how to obtain GLNs, determine how many they need, and maintain clean hierarchies that reflect real operations.
With proper processes in place—naming standards, hierarchy management, retirement rules, and a clear GLN registry—pharmacies can avoid errors, prevent data mismatches, and support seamless traceability across the supply chain.
Want to learn more about GLNs? Explore the related articles in our blog series to dive deeper into how GLNs work, why they matter, and how they’re used across the supply chain.